Eris Lifesciences to acquire 30% of Swiss Parenterals
after close1 source ↓written by the desknot a recommendation
- of Swiss Parenterals
- 30%
- Parenterals Limited
- ₹423.30 cr
- in SPL
- 100%
Eris Lifesciences Limited will acquire 30% of Swiss Parenterals Limited for ₹423.30 cr. This acquisition will be executed through the issuance of equity shares to Mr. Naishadh Shah, increasing ELL's stake in SPL to 100%. The deal is pending necessary stock exchange approvals, which may enhance ELL's market position in the pharmaceutical sector. 💊
Not investment advice. For informational purposes only.